McCulloch Kevin
- SEC CIK
- 0002031695
In the past year, 4 open-market sale filings worth $1.09M and no purchases.
Current role at each company
- XERS Xeris Biopharma Holdings, Inc.See Remarksas of Sep 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.09M
- 4 filings
- Net
- −$1.09M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists McCulloch Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)6:21 PM ET | Sep 1 | Same day | McCulloch KevinSee Remarks | SSale | −15.0K | $8.49 | −$127.3K | −0.9%1.64M after | 10b5-1 |
| Aug 4, 2026 (view filing)5:30 PM ET | Aug 3 | 1 day | McCulloch KevinSee Remarks | SSale | −15.0K | $8.02 | −$120.2K | −0.9%1.68M after | 10b5-1 |
| Jul 2, 2026 (view filing)4:40 PM ET | Jul 1 | 1 day | McCulloch KevinSee Remarks | SSale | −90.0K | $8.03 | −$722.5K | −5.1%1.69M after | 10b5-1 |
| Jan 9, 2026 (view filing) | Jan 8 | 1 day | McCulloch KevinSee Remarks | SSale | −15.0K | $8.00 | −$120.0K | −0.9%1.69M after | 10b5-1 |
| Jun 16, 2025 (view filing) | Jun 13 | 3 days | McCulloch KevinSee Remarks | PPurchase | +25.0K | $4.38 | +$109.5K | +1.5%1.71M after |